David Seaburg
Chief Executive Officer bij STELLA DIAGNOSTICS INC.
Vermogen: 7 775 $ op 31-03-2024
Profiel
David Seaburg is currently the Chief Executive Officer & Director at Stella Diagnostics, Inc. and the Director at Stella Diagnostics LLC.
Previously, he worked as the Managing Director & Head-Sales Trading at Cowen & Co. LLC from 1998 to 2020.
He also served as the Director at RegenETP, Inc. from 2021 to 2023.
Mr. Seaburg obtained his undergraduate degree from Northeastern University in 1993.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
REGENETP INC.
0.97% | 20-03-2023 | 71 272 ( 0.97% ) | 7 127 $ | 31-03-2024 |
STELLA DIAGNOSTICS INC.
0.10% | 30-06-2022 | 9 000 ( 0.10% ) | 648 $ | 31-03-2024 |
Actieve functies van David Seaburg
Bedrijven | Functie | Begin |
---|---|---|
STELLA DIAGNOSTICS INC. | Chief Executive Officer | 22-04-2022 |
Stella Diagnostics LLC
Stella Diagnostics LLC Medical SpecialtiesHealth Technology Stella Diagnostics LLC engages in the provision of molecular diagnostic services. Its StellaDX’s mass spec proteomic assays offers physicians insight into the molecular properties of patients’ tissue to determine if the disease is stable, progressing or turning cancerous. The company is headquartered in New York, NY. | Director/Board Member | 25-02-2021 |
Eerdere bekende functies van David Seaburg
Bedrijven | Functie | Einde |
---|---|---|
REGENETP, INC. | Chief Executive Officer | 01-09-2021 |
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Sales & Marketing | 01-05-2020 |
Opleiding van David Seaburg
Northeastern University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
REGENETP, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Finance |
Stella Diagnostics LLC
Stella Diagnostics LLC Medical SpecialtiesHealth Technology Stella Diagnostics LLC engages in the provision of molecular diagnostic services. Its StellaDX’s mass spec proteomic assays offers physicians insight into the molecular properties of patients’ tissue to determine if the disease is stable, progressing or turning cancerous. The company is headquartered in New York, NY. | Health Technology |
Stella Diagnostics, Inc. |